stockrowCharles River Laboratories International, Inc. (CRL) vs Illumina, Inc. (ILMN)
- Charles River Laboratories International, Inc. CRL 313.98 −3.77%
- Illumina, Inc. ILMN 209.82 −7.38%
Charles River Laboratories International, Inc. and Illumina, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $31.5B against $14.9B — 2.1× the size. Illumina, Inc. trades at the lower P/E: 35.6× against 300×. Illumina, Inc. grew revenue faster over the last twelve months: 5.83% against −1.16%. Illumina, Inc. has the higher net margin (19.7% vs 1.01%) and the higher return on invested capital (16.7% vs 1.81%). Across the 22 metrics below, Illumina, Inc. leads on 18 and Charles River Laboratories International, Inc. on 4.
Valuation
Profitability
| Metric | CRL | ILMN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.33% | 67.87% | 48.32% |
| Operating margin | 4.00% | 21.18% | (5.68%) |
| Net margin | 1.01% | 19.72% | (4.10%) |
| Free cash flow margin | 10.05% | 23.29% | 0.00% |
| Return on equity | 1.21% | 32.39% | 0.00% |
| Return on assets | 0.54% | 13.78% | (6.05%) |
| Return on invested capital | 1.81% | 16.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack